An interventional study of Physician-Led Face-to-Face Exercise Instruction and Video-Based Exercise Instruction in Plantar Fasciitis of Both Feet and Plantar Fascitis, sponsored by Balikesir Ataturk City Hospital. Recruiting at 2 sites in Turkey (Türkiye). Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-10-14.
Sponsored by Balikesir Ataturk City Hospital · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 42 studies in Fasciitis, Plantar with a site in Turkey — 15 open to participants now, 16 under way, none of them phase 3. Fasciitis, Plantar · Turkey.
Among the 42 studies in Fasciitis, Plantar with a site in Turkey, this one has the largest planned enrollment of the 28 interventional ones that give a count, is one of 9 that started in 2026, is one of 28 with no phase, reaches primary completion later than 8 of the 15 other live ones, and was the 32nd registered.
224 studies on the registry are indexed under Fasciitis, Plantar; 59 are open to participants now.
Browse Fasciitis, Plantar studies →15 of the 42 studies in Fasciitis, Plantar with a site in Turkey are open now. Recruiting first, the newest first:
Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey · Sites in Turkey
Ages 18–65 · Healthy volunteers
Ankara City Hospital Bilkent · Sites in Turkey
Ages 18–65
Karamanoğlu Mehmetbey University · Sites in Turkey
Ages 18–65
Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey · Sites in Turkey
Ages 18–65 · Healthy volunteers
Ankara City Hospital Bilkent · Sites in Turkey
Ages 18–70
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 29 Fasciitis, Plantar studies recruiting now, 5 (17%) set no upper age limit and 21 (72%) stop at 75 or younger; none take children under 18; 4 take healthy volunteers.
This study: 18 Years to 70 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
42 studies; the count open now beside each. This study's row is marked.
First in 2018; this study’s year is marked. 9 started in 2026.
This study's planned enrollment of 300 is above the median of 56 across 194 interventional studies indexed under Fasciitis, Plantar.
Median enrollment 57 across the 28 interventional studies, 77 across the 14 observational. Of the 22 that completed or were terminated, 1 (5%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 42 has an industry lead sponsor. The 10 most frequent:
Balikesir Ataturk City Hospital is the lead sponsor of 3 studies on the registry; 3 are open to participants now.
Balikesir Ataturk City Hospital has 1 study filed under Fasciitis, Plantar — fewer than ten, so there is no comparison to draw.
7 of the studies in Fasciitis, Plantar with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07761000Ahi Evran University Education and Research HospitalEvaluation of Spinal Posture, Balance, and Core Muscle Endurance in Individuals With Plantar Fasciitis | 2026-12-01 |
| NCT07878273Sultan Abdulhamid Han Training and Research Hospital, Istanbul, TurkeyTibial Nerve Size and Clinical Features in Chronic Plantar Fasciitis | 2026-12-01 |
| NCT07754214Karamanoğlu Mehmetbey UniversityOutcomes of the Proprioception and Strengthening Exercise Program in Chronic Plantar Fasciitis | 2026-12-31 |
| NCT07688876Ankara City Hospital BilkentPulsed Radiofrequency Versus 5% Dextrose Injection in Chronic Plantar Fasciitis | 2027-01-01 |
| NCT07626723Kirsehir Ahi Evran UniversitesiESWT in the Treatment of Plantar Fasciitis | 2027-02-01 |
Add all 7 to your calendar (.ics) → With an account.
Among the 42 studies in Fasciitis, Plantar with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This prospective, single-center, two-arm, parallel-group randomized non-inferiority trial will compare physician-led face-to-face exercise instruction with standardized video-based exercise instruction in adults with plantar fasciitis. Participants will be randomized in a 1:1 ratio to receive either face-to-face exercise training by an orthopedic physician or access to a standardized exercise video via QR code/web link. The exercise content will be identical in both groups; only the method of instruction will differ. The primary outcome will be the change in the Foot Function Index total/index score from baseline to 3 months. Secondary outcomes will include pain score, Foot Function Index subscales, exercise knowledge, exercise adherence, education time, video viewing status, additional treatment requirement, and patient satisfaction.
Plantar fasciitis is a common cause of chronic plantar heel pain and may lead to functional limitation and reduced quality of life. Exercise education is an important component of conservative treatment; however, in busy outpatient settings, the time available for detailed face-to-face instruction may be limited. Standardized video-based education may provide a practical alternative by delivering the same exercise content in a reproducible format.
This study will evaluate whether video-based exercise instruction is non-inferior to physician-led face-to-face instruction in patients with plantar fasciitis. All participants will receive standard information about plantar fasciitis, load management, footwear recommendations, weight control, short-term analgesic or anti-inflammatory use when needed, and heel pad or insole support. The home exercise program will be identical in both groups and will include plantar fascia-specific stretching, gastrocnemius/soleus stretching, plantar fascia self-massage, gradual toe raises, and towel pull exercises.
Assessments will be performed at baseline, 1 month, and 3 months after randomization. Functional status will be assessed using the Foot Function Index, and pain will be measured using a 0-10 numerical rating scale. Exercise knowledge, adherence, education duration, video viewing behavior, additional treatment use, and satisfaction will also be recorded.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Blood cells that help blood clot. Too few raises the risk of bleeding and bruising. A usual adult range is about 150–400 × 10⁹/L (150,000–400,000 per µL); each lab has its own reference range.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Platelets
Blood cells that help blood clot. Too few raises the risk of bleeding and bruising. A usual adult range is about 150–400 × 10⁹/L (150,000–400,000 per µL); each lab has its own reference range.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants in this arm will receive standard plantar fasciitis education and physician-led face-to-face instruction of the home exercise program. The orthopedic physician will explain and demonstrate the exercises during the baseline visit. The exercise program will include plantar fascia-specific stretching, gastrocnemius/soleus stretching, plantar fascia self-massage, gradual toe raises, and towel pull exercises.
Behavioral: Physician-Led Face-to-Face Exercise Instruction
Participants in this arm will receive standard plantar fasciitis education and a QR code or web link providing access to a standardized exercise video prepared by the study team. The video will not be watched in the outpatient clinic; participants will be instructed to perform the exercises at home by watching the video. The exercise content, order, repetitions, and frequency will be identical to the physician-led group.
Behavioral: Video-Based Exercise Instruction
Face-to-face instruction and demonstration of a standardized home exercise program by an orthopedic physician. The program includes plantar fascia-specific stretching, gastrocnemius/soleus stretching, plantar fascia self-massage, gradual toe raises, and towel pull exercises.
Access to a standardized home exercise video prepared by the study team via QR code or web link. Participants will be instructed to watch the video at home and perform the same exercise program used in the physician-led group.
Change in Foot Function Index Total/Index Score From Baseline to 3 Months
The Foot Function Index total/index score is a patient-reported measure of foot pain, disability, and activity limitation, converted to a 0-100 score. Higher scores indicate worse foot-related function. The primary endpoint will be the change from baseline to 3 months, calculated as baseline FFI score minus 3-month FFI score; higher positive values indicate greater clinical improvement.
Time frame: Baseline and 3 months after randomization
Change in Numeric Rating Scale Pain Score From Baseline to 1 and 3 Months
Heel pain while walking during the previous week will be assessed using an 11-point numerical rating scale ranging from 0 to 10, where 0 indicates no pain and 10 indicates unbearable pain. Change scores will be calculated from baseline to each follow-up visit.
Time frame: Baseline, 1 month, and 3 months after randomization
Change in Foot Function Index Pain Subscale Score From Baseline to 1 and 3 Months
The pain subscale of the Foot Function Index will be used to assess foot-related pain. Scores will be converted according to the standard Foot Function Index scoring method; higher scores indicate worse pain.
Time frame: Baseline, 1 month, and 3 months after randomization
Change in Foot Function Index Disability Subscale Score From Baseline to 1 and 3 Months
The disability subscale of the Foot Function Index will be used to assess foot-related functional disability. Higher scores indicate greater disability.
Time frame: Baseline, 1 month, and 3 months after randomization
Plan to share: No — Individual participant data will not be publicly shared because the ethics approval and informed consent do not include public sharing of participant-level data. De-identified aggregate study results will be reported in scientific presentations and publications.
No publications or documents are linked to this record.
Started Feb 2026 (actual). Primary completion is estimated for Nov 2026, 9 months after the start.
Of 104 non-industry interventional studies with no phase under Fasciitis, Plantar, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 21. This study's planned 9 months is below that.
Counting every sponsor, half of 109 studies reached it within 11 months; a quarter within 6 and three quarters within 22.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Balikesir Ataturk City Hospital